Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo... Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused...
This role is for a seasoned Pharma forecaster who will develop product-specific short-term and long-term forecasts models... to stay up to date on leading analytic capabilities, both within and outside of pharma, which can be applied within the...
Job Description: Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in... of aligned global scientific messaging in Ascendis Pharma's Scientific Communication Platforms across current and future...
Super FMCGs: LKP Securities' top FMCG stock picks include Mrs.Bector Food Specialities, CCL Products, and Jyothy Laboratories Ltd over robust volume growth and revenue margins. Continue Reading »
The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which was fueled by the United States Federal Reserves (FED) big 50 basis point rate cut on Wednesday. Continue Reading »
Foreign investors significantly increased their investments in Indian markets for a second day following the US Federal Reserve’s steeper-than-expected interest rate cut, with Nifty 50 and Sensex hitting record highs on Friday and boosting investor wealth by $7 trillion. Continue Reading »
HDB Financial Services Ltd, a subsidiary of HDFC Bank, has received approval for an IPO. The IPO will comprise a fresh issue of shares worth ₹2,500 crore and an OFS. Continue Reading »
Ami Organics' strength in R&D and manufacturing large-scale pharma intermediates will help it increase the contract revenue share in its pharma intermediates business and provide long-term sales visibility. Continue Reading »
Popular Foundations IPO;: On September 13, 2024, the IPO subscription for Popular Foundations began ending on 18 September. Here are the steps to check allotment status online, GMP as focus shifts to listing Continue Reading »
Despite recent volatility, Adani Energy Solutions shows promise, with Cantor initiating an 'overweight' recommendation and a target price of ₹2,251. The firm anticipates robust growth driven by its diverse operations in India's energy sector. Continue Reading »